These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3499514)

  • 21. [Concomitant use of 2 immunomodulators].
    Nobenaga M
    Ryumachi; 1988 Dec; 28(6):455-7. PubMed ID: 3249991
    [No Abstract]   [Full Text] [Related]  

  • 22. T lymphocyte subpopulations in rheumatoid arthritis.
    Meijer CJ; Lafeber GJ; Cnossen J; Damsteeg MG; Cats A
    J Rheumatol; 1982; 9(1):18-24. PubMed ID: 6979628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapy with chlorambucil in progressive chronic polyarthritis].
    Thumb N; Horak W
    Wien Z Inn Med; 1968; 49(12):462-70. PubMed ID: 4187786
    [No Abstract]   [Full Text] [Related]  

  • 24. [Endoxan in the treatment of psoriatic arthritis and rheumatoid arthritis].
    Maldykowa H; Chwalińska-Sadowska H
    Reumatologia; 1972; 10(3):253-7. PubMed ID: 4634603
    [No Abstract]   [Full Text] [Related]  

  • 25. Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis.
    Tsujimura S; Saito K; Nawata M; Nakayamada S; Tanaka Y
    Ann Rheum Dis; 2008 Mar; 67(3):380-8. PubMed ID: 17660216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A case of rheumatoid arthritis associated with leukocytopenia during D-penicillamine treatment].
    Negishi M; Sato H; Sekine F; Mita S; Ono I; Kobayashi K; Oseto Y; Hamai T; Takahashi T
    Arerugi; 1982 Jun; 31(6):350-4. PubMed ID: 7181659
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunomodulator (author's transl)].
    Mizushima Y
    Ryumachi; 1980 Feb; 20(1):57-62. PubMed ID: 6966831
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cyclophosphamide in the treatment of rheumatoid arthritis].
    Girelli M; Gaido A
    Minerva Med; 1972 Mar; 63(20):1150-3. PubMed ID: 5018859
    [No Abstract]   [Full Text] [Related]  

  • 29. [T-lymphocyte subpopulations in chronic inflammatory rheumatism].
    Faure G; Bach MA; Bene MC; Kahn MF; Bach JF; Gaucher A
    Rev Rhum Mal Osteoartic; 1982 May; 49(6):439-45. PubMed ID: 6213999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of chrysotherapy on T-lymphocyte subpopulations in rheumatoid arthritis.
    Pfreundschuh M; Parino G; Gram N; Bröker A; Gause A; Hunstein W
    Z Rheumatol; 1983; 42(6):328-31. PubMed ID: 6229937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Side effects of immunomodulators and countermeasures].
    Kashiwazaki S; Suzuki S; Okada J
    Ryumachi; 1988 Dec; 28(6):460-3. PubMed ID: 2977863
    [No Abstract]   [Full Text] [Related]  

  • 32. Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis.
    Yudoh K; Matsuno H; Nakazawa F; Yonezawa T; Kimura T
    Arthritis Rheum; 2000 Mar; 43(3):617-27. PubMed ID: 10728756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure of amiprilose hydrochloride, a novel anti-inflammatory agent.
    Linhardt RJ; Baenziger NC; Ronsen B
    J Pharm Sci; 1990 Feb; 79(2):158-62. PubMed ID: 2324965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Desensitization to salazopyrine in rheumatoid polyarthritis].
    Lioté F; Kuntz D
    Rev Rhum Mal Osteoartic; 1991 Feb; 58(2):139. PubMed ID: 1675020
    [No Abstract]   [Full Text] [Related]  

  • 35. Shift toward T helper 1 cytokines by type II collagen-reactive T cells in patients with rheumatoid arthritis.
    Park SH; Min DJ; Cho ML; Kim WU; Youn J; Park W; Cho CS; Kim HY
    Arthritis Rheum; 2001 Mar; 44(3):561-9. PubMed ID: 11263770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Function and health-related quality of life: results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group.
    Strand V; Tugwell P; Bombardier C; Maetzel A; Crawford B; Dorrier C; Thompson A; Wells G
    Arthritis Rheum; 1999 Sep; 42(9):1870-8. PubMed ID: 10513801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experience in the use of antilymphocyte gamma globulin for the treatment of rheumatoid arthritis].
    Mal'chenko GA; Shmorgun SS; Antonenko VT; Stetsenko VN; Skuratovskiĭ MF
    Vrach Delo; 1980 Nov; (11):70-3. PubMed ID: 6162276
    [No Abstract]   [Full Text] [Related]  

  • 38. [Correction of immunoregulatory disorders in seronegative and seropositive rheumatoid arthritis].
    Seĭsenbaev ASh
    Ter Arkh; 1985; 57(8):132-5. PubMed ID: 3878005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New approaches to pharmacotherapy of rheumatoid arthritis: clinical perspectives of the drug subreum (OM-89)].
    Nasonov EL; Chichasova NV
    Klin Med (Mosk); 1999; 77(5):12-6. PubMed ID: 10394779
    [No Abstract]   [Full Text] [Related]  

  • 40. Autoantibodies against Tmu and B lymphocytes in patients with rheumatoid arthritis.
    Meijer CJ; Cnossen J; Lafeber GJ; Damsteeg MJ; Cats A
    Clin Exp Immunol; 1982 Feb; 47(2):368-80. PubMed ID: 6978781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.